Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8752917rdf:typepubmed:Citationlld:pubmed
pubmed-article:8752917lifeskim:mentionsumls-concept:C0032659lld:lifeskim
pubmed-article:8752917lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:8752917lifeskim:mentionsumls-concept:C0221284lld:lifeskim
pubmed-article:8752917lifeskim:mentionsumls-concept:C0282587lld:lifeskim
pubmed-article:8752917lifeskim:mentionsumls-concept:C1332714lld:lifeskim
pubmed-article:8752917lifeskim:mentionsumls-concept:C1334863lld:lifeskim
pubmed-article:8752917lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:8752917lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:8752917pubmed:issue2lld:pubmed
pubmed-article:8752917pubmed:dateCreated1996-11-7lld:pubmed
pubmed-article:8752917pubmed:abstractTextCD56 is a member of the neural cell adhesion molecule family expressed on cells of the central nervous system and also on NK cells. Previous studies suggest the involvement of CD56 in effector-to-target cell conjugation mediated by NK cells. It was shown recently that CD56 is also expressed by subpopulations of CD8+ and CD4+ T cells. The present study describes the functional characteristics of CD4+CD56+ T cell lines established from blood of multiple sclerosis patients by stimulation with myelin basic protein (MBP). CD4+CD56+, MBP-specific T cell lines were able to lyse MBP-pulsed target cells in an HLA class II-restricted fashion. At the same time, they mediated MHC-unrestricted lysis of CD56+ target cells such as CD56+ lymphoid or glial tumor cells, but not of the typical NK target, K562. A number of experimental results including separation of CD4+CD56+ T cells into CD56 high and low expressing populations, cold target inhibition, as well as killing of CD56-transfected cells indicate that homotypic CD56 interactions are involved in the MHC-unrestricted lysis. CD56 interactions are not sufficient but are required for effector/target interaction. Our findings raise the possibility that CD4+CD56+ T cells sharing properties of both typical Ag-specific Th0-like T cells and NK cells might be involved in damage of tissues expressing CD56/neural cell adhesion molecule, such as the central nervous system. Thus, we provide evidence for a novel mechanism that could lead to organ-specific autoreactivity.lld:pubmed
pubmed-article:8752917pubmed:languageenglld:pubmed
pubmed-article:8752917pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8752917pubmed:citationSubsetAIMlld:pubmed
pubmed-article:8752917pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8752917pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8752917pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8752917pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8752917pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8752917pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8752917pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8752917pubmed:statusMEDLINElld:pubmed
pubmed-article:8752917pubmed:monthJullld:pubmed
pubmed-article:8752917pubmed:issn0022-1767lld:pubmed
pubmed-article:8752917pubmed:authorpubmed-author:MartinRRlld:pubmed
pubmed-article:8752917pubmed:authorpubmed-author:LORRlld:pubmed
pubmed-article:8752917pubmed:authorpubmed-author:McFarlandHHlld:pubmed
pubmed-article:8752917pubmed:authorpubmed-author:Dhib-JalbutSSlld:pubmed
pubmed-article:8752917pubmed:authorpubmed-author:van NoortJ...lld:pubmed
pubmed-article:8752917pubmed:authorpubmed-author:VergelliMMlld:pubmed
pubmed-article:8752917pubmed:issnTypePrintlld:pubmed
pubmed-article:8752917pubmed:day15lld:pubmed
pubmed-article:8752917pubmed:volume157lld:pubmed
pubmed-article:8752917pubmed:ownerNLMlld:pubmed
pubmed-article:8752917pubmed:authorsCompleteYlld:pubmed
pubmed-article:8752917pubmed:pagination679-88lld:pubmed
pubmed-article:8752917pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8752917pubmed:meshHeadingpubmed-meshheading:8752917-...lld:pubmed
pubmed-article:8752917pubmed:meshHeadingpubmed-meshheading:8752917-...lld:pubmed
pubmed-article:8752917pubmed:meshHeadingpubmed-meshheading:8752917-...lld:pubmed
pubmed-article:8752917pubmed:meshHeadingpubmed-meshheading:8752917-...lld:pubmed
pubmed-article:8752917pubmed:meshHeadingpubmed-meshheading:8752917-...lld:pubmed
pubmed-article:8752917pubmed:meshHeadingpubmed-meshheading:8752917-...lld:pubmed
pubmed-article:8752917pubmed:meshHeadingpubmed-meshheading:8752917-...lld:pubmed
pubmed-article:8752917pubmed:meshHeadingpubmed-meshheading:8752917-...lld:pubmed
pubmed-article:8752917pubmed:meshHeadingpubmed-meshheading:8752917-...lld:pubmed
pubmed-article:8752917pubmed:meshHeadingpubmed-meshheading:8752917-...lld:pubmed
pubmed-article:8752917pubmed:meshHeadingpubmed-meshheading:8752917-...lld:pubmed
pubmed-article:8752917pubmed:meshHeadingpubmed-meshheading:8752917-...lld:pubmed
pubmed-article:8752917pubmed:meshHeadingpubmed-meshheading:8752917-...lld:pubmed
pubmed-article:8752917pubmed:year1996lld:pubmed
pubmed-article:8752917pubmed:articleTitleA novel population of CD4+CD56+ myelin-reactive T cells lyses target cells expressing CD56/neural cell adhesion molecule.lld:pubmed
pubmed-article:8752917pubmed:affiliationNeuroimmunology Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD 20892, USA.lld:pubmed
pubmed-article:8752917pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8752917pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8752917lld:pubmed